Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
EQT Fund Management S.a r.l. (CIK 1834239) reported $1.02B across 3 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: WAY ($599.8M, 58.77%), OCS ($156.9M, 15.37%), ($113.3M, 11.10%), PHVS ($96.7M, 9.48%), ($53.9M, 5.28%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | WAY | WAYSTAR HLDG CORP | $599.8M | 58.77% | 24.9M | Hold |
| 2 | OCS | OCULIS HOLDING AG | $156.9M | 15.37% | 5.9M | Hold |
| 3 | EVOMMUNE INC | $113.3M | 11.10% | 4.9M | Hold | |
| 4 | PHVS | PHARVARIS N V | $96.7M | 9.48% | 3.4M | Hold |
| 5 | AGOMAB THERAPEUTICS NV | $53.9M | 5.28% | 5.1M | New |
Source: SEC Form 13F filings · as of 2026-03-31